XBiotech appoints Dr. Thomas Kündig and Craig Rademaker to Board of Directors

XBiotech Inc.

Dr. Thomas Kündig, Director of Dermatology at University Hospital Zurich, appointed to Board and Compensation Committee effective June 24, 2025.
Craig Rademaker, private equity leader with 25+ years in finance, appointed to Board and Audit Committee, effective same date.
Both appointments expire at the 2025 Annual General Meeting; committees now include Jan-Paul Waldin, Dr. Peter Libby, and the new members.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.